ANTICANCER POTENTIAL OF AMPHIOCTOPUS AEGINA INK: AN INTEGRATED IN-VITRO AND IN-SILICO STUDY
DOI:
https://doi.org/10.55251/jmbfs.14403Keywords:
Colorectal cancer, KRAS4B mutation, PI3K/AKT pathway, In-silico analysis, Marine bioactive compoundsAbstract
Colorectal cancer is one of the major health challenges for man-kind. The genetic modifications, leading to altered signaling pathways has increased the severity of the disease and hence increased mortality. In this study aqueous ink extract of Amphioctopus aegina, commonly known as marbled octopus, has been investigated for the presence of bioactive compounds and its anticancer potential using experimental and computational approach. Cytotoxicity of the ink extract used on colorectal cancer cell lines HT-29, showed a dose-dependent reduction in cell viability with an IC50 of 82.68 ± 0.05 µg/mL. Further, the bioactive compounds were identified using LC-MS. Based on high-confidence spectral scores (≥95 %) 34 compounds were short-listed. ADMET profiling was carried out and eight compounds with favorable pharmacokinetic properties were considered for molecular docking studies on KRAS4B (G12V) and E17K-AKT1, the most commonly mutated proteins in colorectal cancer. Most of the compounds showed good binding affinity, notably dihydro-3-coumaric acid showed stronger interactions with both the proteins, while indole-3-carbinol showed good binding affinity with E17K-AKT1. The stability of these complexes was validated using Normal mode analysis (NMA). Collectively, the findings suggest that A. aegina ink extract contains bioactive compounds with potential anticancer activity, showing predicted interactions with KRAS and AKT pathways. This study highlights the therapeutic potential of marine-derived natural products as promising candidates for the development of novel anticancer agents.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Gandasi Ravikumar Sahana, Biljo V Joseph

This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers published in the Journal of Microbiology, Biotechnology and Food Sciences are published under a CC-BY licence (CC-BY 4.0). Published materials can be shared (copy and redistribute the material in any medium or format) and adapted (remix, transform, and build upon the material for any purpose, even commercially) with specifying the author(s).